PEPTIDOMIMETIC BACE-1 INHIBITOR PRODRUGS FOR ALZHEIMER’S DISEASE: THE POTENTIAL OF GLUCOSYLATION TO CIRCUMVENT THE BLOOD-BRAIN BARRIER

Post
Filter